Septerna, Inc. (SEPN) News
Follow Septerna, Inc. (SEPN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Septerna announces inducement grant under Nasdaq listing rule
Septerna, Inc. announced an inducement grant under Nasdaq listing rule. The filing details were not provided in the source body.
EQUITY | Sep 10, 2026, 08:05 PM UTC
L
Septerna grants 275,000-share option to new Chief Medical Officer
Septerna, Inc. said it granted a non-qualified stock option to purchase up to 275,000 shares of its common stock to Rajiv Patni, M.D., its newly appointed Chief Medical Officer. The grant is made under Nasdaq Listing Rul
EQUITY | Sep 10, 2026, 08:01 PM UTC
L
SEPN to report oral PTH agonist Phase I data in Q1
SEPN is advancing an oral PTH receptor agonist for hypoparathyroidism, with full Phase I data expected in Q1 next year. The company is also expanding into Graves' disease, osteoporosis and mast cell diseases.
EQUITY | Sep 08, 2026, 01:17 PM UTC
M
SEPN’s SEP-479 phase I data expected in Q1 next year
SEP-479, an oral PTH receptor agonist, is advancing with phase I data expected in Q1 next year. The program targets improved calcium control and patient adherence, with additional updates for Graves’, osteoporosis and ma
EQUITY | Sep 08, 2026, 12:54 PM UTC
L
Septerna to participate in investor conferences in September
Septerna management said it will participate in investor conferences during September, according to a company announcement.
EQUITY | Sep 01, 2026, 12:07 PM UTC
L
SEPN - Septerna to Participate in Upcoming Investor Conferences
SEPN - Septerna to Participate in Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 12:00 PM UTC
L
Septerna appoints Rajiv Patni, M.D., as Chief Medical Officer
Septerna appoints industry veteran Rajiv Patni, M.D., as Chief Medical Officer, according to TradeXchange Newsdesk.
EQUITY | Aug 25, 2026, 12:00 PM UTC
H
DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Tuesday. Shares of DigitalOcean Holdings Inc (NYSE: DOCN ) rose sharply after the company announced it expects a year-over-year increase in second-qu
EARNINGS | Jul 07, 2026, 02:00 PM UTC
L
Guggenheim Maintains Buy on Septerna, Lowers Price Target to $45
Guggenheim analyst Seamus Fernandez maintains Septerna (NASDAQ: SEPN ) with a Buy and lowers the price target from $52 to $45.
EQUITY | Jul 01, 2026, 01:00 PM UTC
L
HC Wainwright & Co. Reiterates Buy on Septerna, Maintains $40 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Septerna (NASDAQ: SEPN ) with a Buy and maintains $40 price target.
EQUITY | Jul 01, 2026, 12:19 PM UTC
L
Truist Securities Maintains Buy on Septerna, Raises Price Target to $43
Truist Securities analyst Srikripa Devarakonda maintains Septerna (NASDAQ: SEPN ) with a Buy and raises the price target from $35 to $43.
EQUITY | Jul 01, 2026, 11:53 AM UTC